| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Intensity Therapeutics, Inc.
13G/A
INTS · 45828J103
|
3.9% |
7/9/2025
Event 6/30/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.